JP Morgan Upgrades Corteva to Overweight, Lowers Price Target to $19

Benzinga Newsdesk www.benzinga.com Neutral 40.4%

Neg 0% Neu 40.4% Pos 0%

JP Morgan analyst Jeffrey Zekauskas upgrades Corteva (NYSE:CTVA) from Neutral to Overweight and lowers the price target from $83 to $19.